Product Name | MF | CAS | Details |
---|
RAPTA-C | C16H23Cl2N3PRu | 372948-28-2 | Details |
RSS0680 | C52H64N10O6S3 | 2769753-48-0 | Details |
Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate | Details |
Ras Inhibitory Peptide acetate | Details |
Ro 41-5253 | C28H36O5S | 144092-31-9 | Details |
Protein kinase inhibitor 6, 10 mM in DMSO | C13H9FN2S | 348-45-8 | Details |
Pomalidomide-PEG4-Ph-NH2, 10 mM in DMSO | C27H32N4O8 | 1818885-63-0 | Details |
Moiramide B | C25H31N3O5 | 155233-31-1 | Details |
SDZ 224-015 | C30H35Cl2N3O9 | 161511-45-1 | Details |
RS 100329 hydrochloride | C20H26ClF3N4O3 | 1215654-26-4 | Details |
PFB-FDGlu | C39H32F5NO16 | 209540-62-5 | Details |
SB-237376, 10 mM in DMSO | C20H25N3O5 | 179258-59-4 | Details |
PD 407824 | C20H12N2O3 | 622864-54-4 | Details |
MMP-9-IN-7, 10 mM in DMSO | C16H15ClN4O2S2 | 333746-76-2 | Details |
PRLX-93936 HCL | C21H25ClN4O2 | 1094210-96-4 | Details |
S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
N-Boc-4-hydroxy-L-proline methyl ester | C11H19NO5 | 102195-79-9 | Details |
MK-0773, 10 mM in DMSO | C27H34FN5O2 | 606101-58-0 | Details |
PPY A | C22H20N4O2 | 875634-01-8 | Details |
p53-Mdm2 inhibitor 4 | C23H20FN3O3 | 350678-63-6 | Details |
NDSB-211, 10 mM in DMSO | C7H19NO5S | 38880-58-9 | Details |
Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
mTOR inhibitor 9d | C21H23N5O3S | 1144075-38-6 | Details |
mTOR inhibitor 9e | C22H23N5O2S | 1144075-40-0 | Details |
Neuromedin U (rat) acetate | Details |
PF-17 | C21H28N4O5S | 2697145-21-2 | Details |
Pteroside B | C20H28O7 | 29774-74-1 | Details |
MJN68390 | 1956368-39-0 | Details |
S3I-201, 10 mM in DMSO | C16H15NO7S | 501919-59-1 | Details |
MK-0674 | C26H27F6N3O2 | 887781-62-6 | Details |
Ochratoxin B | C20H19NO6 | 4825-86-9 | Details |
PKM2 inhibitor G, 10 mM in DMSO | C16H15NO3S | 904457-46-1 | Details |
PA3552-IN-1, 10 mM in DMSO | C13H8ClFN2O4 | 1008121-12-7 | Details |
Plogosertib | C34H48N8O3 | 1137212-79-3 | Details |
Quilseconazole Formic acid(1340593-70-5 Free base) | Details |
mTOR inhibitor 13 | C24H22N6O2S | 1144075-44-4 | Details |
PDE5-IN-9 | C18H14N4S | 157862-84-5 | Details |
PF-07258669 | C25H27FN6O2 | 2755890-53-8 | Details |
p53 Activator 7 | C27H32F3N4OP | 2849340-59-4 | Details |
Schistoflrfamide acetate | Details |
Quilseconazole Formic acid(1340593-70-5 Free base), 10 mM in DMSO | Details |
MJ 15 | C23H17Cl3N4O | 944154-76-1 | Details |
PF-04957325, 10 mM in DMSO | C14H15F3N8OS | 1305115-80-3 | Details |
Pseudane IX | C18H25NO | 55396-45-7 | Details |
Nepasaikosaponin K | C48H80O18 | 405229-61-0 | Details |
NFAT Inhibitor-2, 10 mM in DMSO | C22H20F2N2O4S | 422546-87-0 | Details |
Protein kinase G inhibitor-2, 10 mM in DMSO | C14H18N2O2S | 612829-80-8 | Details |
Pincainide | C16H24N2O | 83471-41-4 | Details |
pobilukast | C26H34O5S | 107023-41-6 | Details |
mTOR inhibitor 9f | C25H23N5O2S | 1144075-42-2 | Details |
mTOR inhibitor 9a | C20H21N5O2S | 1144075-32-0 | Details |
PLH1215 | 1332084-64-6 | Details |
OPC18750 HCl, 10 mM in DMSO | 145364-90-5 | Details |
Protein kinase G inhibitor-1, 10 mM in DMSO | C14H18N2O2S | 354544-70-0 | Details |
RE-640 | C20H16Cl2N4 | 140926-75-6 | Details |
NSC 122393 | C20 H8 Br4 O5 | 73654-97-4 | Details |
Povorcitinib phosphate, 10 mM in DMSO | C23H25F5N7O5P | 1637677-33-8 | Details |
SEW06622 | C21H26N2O2 | 261349-28-4 | Details |
mTOR inhibitor 9b | C21H23N5O2S | 1144075-34-2 | Details |
SF-22 (NPY Y2 antagonist) | C28H26N2O3S | 824981-55-7 | Details |
RORγ inverse agonist 1 | C22H20F3N3O3S | 529500-72-9 | Details |
PROT-IN-1, 10 mM in DMSO | C23H22N2O | 329935-45-7 | Details |
MM41, 10 mM in DMSO | C44H66N10O6 | 1429028-96-5 | Details |
PI3K-IN-46, 10 mM in DMSO | C13H9N3OS | 304645-61-2 | Details |
Pranazepide | C26H19FN4O2 | 150408-73-4 | Details |
PK095, 10 mM in DMSO | C20H18N4O2S | 380314-37-4 | Details |
OUL232, 10 mM in DMSO | C10H10N4O2S | 943119-42-4 | Details |
MRE3008F20 | C21H20N8O3 | 252979-43-4 | Details |
PAPA NONOate | C6H16N4O2 | 146672-58-4 | Details |
MIV-247 | C17H24F3N3O4 | 1352817-76-5 | Details |
N-Demethylricinine, 10 mM in DMSO | C7H6N2O2 | 21642-98-8 | Details |
Prolyl-4-hydroxylase Inhibitor 11 | C12H8N2O4 | 1802-30-8 | Details |
SHEN26, 10 mM in DMSO | C16H19N5O5 | 2647441-36-7 | Details |
Senexin C, 10 mM in DMSO | C28H27N5O | 2375554-02-0 | Details |
N 0861 | C13H17N5 | 141696-90-4 | Details |
PLH2058 | 2525206-41-9 | Details |
p38 MAP Kinase Inhibitor Ⅵ | C16H13FN2OS2 | 421578-46-3 | Details |
NDT 9513727 | C36H35N3O4 | 439571-48-9 | Details |
Pyrintegrin, 10 mM in DMSO | C23H25N5O3S | 1228445-38-2 | Details |
N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide | C14H19ClN4O2 | 1965308-76-2 | Details |
Rovazolac | C21H19F3N2O4S | 1454288-88-0 | Details |
Org41841 | C19H22N4O2S2 | 301847-37-0 | Details |
MMPP | C17H18O3 | 1895957-18-2 | Details |
NT219 | C16H14BrNO5S | 1198078-60-2 | Details |
N2-methylguanine | C6H7N5O | 10030-78-1 | Details |
MK-28, 10 mM in DMSO | C24H20N4O2 | 864388-65-8 | Details |
Paroxypropione, 10 mM in DMSO | C9H10O2 | 70-70-2 | Details |
Notum pectinacetylesterase-1, 10 mM in DMSO | C14H14N4O2S2 | 460727-10-0 | Details |
mTOR inhibitor 9c | C21H22FN5O2S | 1144075-36-4 | Details |
Ryuvidine | C15H12N2O2S | 265312-55-8 | Details |
p38α inhibitor 4 | C14H7F6N3O | 1262406-08-5 | Details |
PF-03049423 | C24H32N6O4 | 954138-07-9 | Details |
SB-674042 | C24H21FN4O2S | 483313-22-0 | Details |
SAX-187, 10 mM in DMSO | C15H13ClN4O2S2 | 554403-49-5 | Details |
Necrostatin-7 | C16H10FN5OS2 | 351062-08-3 | Details |
Mouse IgG2a kappa, Isotype Control | Details |
NecroX-7 | C24H29N3O3S | 1120332-55-9 | Details |
PDD00017272 | C23H25N5O4S3 | 1945950-20-8 | Details |
Orthanilamide, 10 mM in DMSO | C6H8N2O2S | 3306-62-5 | Details |
RO3244794 | C25H19F2NO5 | 361457-01-4 | Details |
Product Total: Product Page: | ||||
123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 |